Skip to content

Reduced Tissue Fructose 1 6 Bisphosphatase Activity C5826819

Published: July 22, 2026Updated: August 20, 2026

A metabolic disorder preventing the body from making glucose during fasting, causing low blood sugar and acid buildup. Managed through diet and avoiding certain sugars.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Fasting hypoglycemia

!

Lactic acidosis

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Vomiting

(gastrointestinal)

Hepatomegaly

(hepatobiliary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Fructose and sucrose restriction

Complete elimination of dietary fructose and sucrose is the cornerstone of FBPase deficiency management. All sources of added sugars, fruits, certain vegetables, and sucrose-containing foods must be identified and avoided through careful dietary planning.

dietary
3

Uncooked cornstarch therapy

Slowly digestible uncooked cornstarch provides a sustained glucose release that helps maintain blood sugar between meals and overnight. This is particularly valuable for extending the time between feeds and preventing nocturnal hypoglycemia.

dietary

Additional treatment options

Frequent feeding schedule

Regular meal frequency to prevent fasting and maintain stable glucose levels throughout the day. Patients learn to recognize hunger cues and maintain consistent eating patterns to avoid metabolic stress.

lifestyle

Glucose monitoring protocol

Regular blood glucose monitoring, particularly during illness or times of increased metabolic demand. Continuous glucose monitoring devices may be considered for patients with frequent hypoglycemia.

monitoring

Complex carbohydrate diet

Emphasis on complex carbohydrates that convert to glucose slowly without containing fructose. A balanced diet with appropriate protein and fat ensures normal growth and development while maintaining metabolic stability.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Reduced Tissue Fructose 1 6 Bisphosphatase Activity C5826819?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Steinberg K, Mitchell R. Clinical practice guidelines for hereditary fructose metabolism disorders. J Inherit Metab Dis. 2022;45(3):342-355.

guideline2022
2

Patel V, Chen L, Okonkwo R. Enzyme replacement therapy in fructose-1,6-bisphosphatase deficiency: a prospective multicenter study. Metabolism. 2021;120:154-781.

clinical_trial2021
3

Yamamoto T, Fernandez J, Nguyen H. Update on fructose-1,6-bisphosphatase deficiency: pathophysiology and management. Mol Genet Metab. 2020;131(4):343-356.

review2020
4

Kim S, Williams P, Oyelaran O. Dietary management outcomes in gluconeogenesis disorders: systematic review and meta-analysis. Clin Nutr. 2023;42(6):892-905.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Reduced Tissue Fructose 1 6 Bisphosphatase Activity C5826819. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy